Cargando…
Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial
INTRODUCTION: Cognitive behavioral therapy (CBT) and U.S. Food and Drug Administration (FDA)-recommended pharmacologic treatments (RPTs; pregabalin, duloxetine, and milnacipran) are effective treatment options for fibromyalgia (FM) syndrome and are currently recommended by clinical guidelines. We co...
Autores principales: | Luciano, Juan V, D’Amico, Francesco, Cerdà-Lafont, Marta, Peñarrubia-María, María T, Knapp, Martin, Cuesta-Vargas, Antonio I, Serrano-Blanco, Antoni, García-Campayo, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203881/ https://www.ncbi.nlm.nih.gov/pubmed/25270426 http://dx.doi.org/10.1186/s13075-014-0451-y |
Ejemplares similares
-
Cost–Utility of Mindfulness-Based Stress Reduction for Fibromyalgia versus a Multicomponent Intervention and Usual Care: A 12-Month Randomized Controlled Trial (EUDAIMON Study)
por: Pérez-Aranda, Adrián, et al.
Publicado: (2019) -
Impact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: a cross-sectional study
por: Gumà-Uriel, Laura, et al.
Publicado: (2016) -
Cost-Utility of Attachment-Based Compassion Therapy (ABCT) for Fibromyalgia Compared to Relaxation: A Pilot Randomized Controlled Trial
por: D’Amico, Francesco, et al.
Publicado: (2020) -
Relationship between behavioural coping strategies and acceptance in patients with fibromyalgia syndrome: Elucidating targets of interventions
por: Rodero, Baltasar, et al.
Publicado: (2011) -
Validation of the Spanish version of the Chronic Pain Acceptance Questionnaire (CPAQ) for the assessment of acceptance in fibromyalgia
por: Rodero, Baltasar, et al.
Publicado: (2010)